IMO the SP of this company should be at $0.70+ based on increase traction of revenues each quarter in the US. I guess there is a worry about the cash burn and cash held.
I really hope that a takeover does not come now at say $0.90 which is a 100%+ premium to current SP as it will undersell all the work the company has achieved over the years.
This happened at Viralytics where the SP was beaten down to $0.615 even after a Chinese medical company took a stake at $0.80 before Merck lobbed a takeover at $1.75.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.684M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 2531288 | 0.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.2¢ | 80879868 | 41 |
View Market Depth
| Last trade - 09.27am 07/08/2025 (20 minute delay) ? |
| AXP (ASX) Chart |
Day chart unavailable